Search results
Medicare Advantage pluses could be cut in 2025
Consumer Affairs· 8 hours agoDespite lower reimbursement rates from Centers for Medicare & Medicaid Services (CMS) and higher medical costs, many Advantage (aka Part C) plan leaders...
UnitedHealthcare Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 11 hours agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). UnitedHealthcare ...
Medicare go-broke date extended to 2036, but warning bells continue ringing
Healthcare Dive via Yahoo Finance· 14 hours agoThe Medicare trustees’ new projection for insolvency is five years later than previous forecasts,...
Social Security now expected to run short on funds in 2035, one year later than previously...
CNBC· 1 day agoPeople leave a Social Security Administration building in Burbank, California. The trust funds the...
...) Releases New Data Showing Over 10 Million People with Medicare Received a Free Vaccine Because...
Sierra Sun Times· 3 days agoOver 10 million people with Part D Medicare received a free vaccine in 2023 thanks to the Inflation Reduction Act, up from just 3 million ...
Medicare Posts $12B Loss for 2023 | ThinkAdvisor
ThinkAdvisor· 18 hours agoThe post-pandemic surge in health care use, the aging U.S. population and health care worker shortages hit Medicare hard in 2023. Payroll tax revenue...
If Medicare Covers Cataract Surgery, Why Are There Bills?
Forbes· 18 hours agoThe daughter of a client called me because she was concerned about how much her mother paid for...
Growth of economy boosts US programs | Northwest Arkansas Democrat-Gazette
Northwest Arkansas Democrat Gazette· 14 hours agoMedicare's go-broke date for its hospital insurance trust fund was pushed back five years to 2036 in...
Charlotte Foust: Do your homework before signing up for a Medicare Advantage plan
The Joplin Globe· 1 day agoMedicare Advantage plans are another way to get your Medicare benefits. Most also offer prescription...
Wegovy & other GLP-1 drugs to get coverage under Medicare Part D
AARP· 6 days agoThe FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are ...